©Author(s) (or their employer(s)) 2026.
World J Crit Care Med. Mar 9, 2026; 15(1): 115599
Published online Mar 9, 2026. doi: 10.5492/wjccm.v15.i1.115599
Published online Mar 9, 2026. doi: 10.5492/wjccm.v15.i1.115599
Table 1 Demographic parameters, mortality scores and duration parameters
| Variable | n (%)/mean ± SD | P value1 | r | P value2 | |
| Age | 61.5 ± 14.6 | 0.594 | -0.186 | 0.071 | |
| Gender | Male/female | 52/43 (54.73/40.85) | 0.464 | 0.100 | 0.333 |
| BMI | 26.2 ± 5.4 | 0.107 | 0.035 | 0.736 | |
| Mortality scores | |||||
| APACHE | 21.7 ± 7.6 | 0.345 | 0.252 | 0.014 | |
| SAPS II | 57.07 ± 15.19 | 0.338 | 0.328 | 0.001 | |
| SOFA | 10.93 ± 3.63 | 0.700 | -0.165 | 0.109 | |
| Duration indicators | |||||
| ETI, yes/no | 84/11 (79.80/10.45) | 0.407 | 0.146 | 0.159 | |
| MV | 9.21 ± 15.12 | 0.013 | 0.280 | 0.006 | |
| LOS | 13.63 ± 16.05 | 0.005 | -0.098 | 0.342 | |
Table 2 Correlation of laboratory findings with fatal outcome
| Variable | T0, day 0 | T1, day 1 | T2, day 3 | T3, day 7 | ||||||||
| P value1 | r | P value2 | P value1 | r | P value2 | P value1 | r | P value2 | P value1 | r | P value2 | |
| WBC | 0.399 | -0.070 | 0.499 | 0.483 | -0.116 | 0.264 | 0.195 | -0.094 | 0.367 | 0.005 | 0.208 | 0.044 |
| RBC | 0.161 | 0.117 | 0.258 | 0.095 | 0.628 | 0.050 | 0.027 | 0.062 | 0.553 | 0.045 | -0.249 | 0.015 |
| PLT | 0.216 | 0.106 | 0.309 | 0.152 | 0.107 | 0.301 | 0.444 | 0.147 | 0.155 | 0.409 | -0.270 | 0.008 |
| NEU | 0.458 | 0.244 | 0.017 | 0.626 | -0.077 | 0.459 | 0.111 | 0.300 | 0.003 | 0.120 | 0.304 | 0.003 |
| LYM | 0.758 | 0.150 | 0.148 | 0.417 | 0.112 | 0.279 | 0.049 | 0.280 | 0.006 | 0.052 | 0.121 | 0.242 |
| pH | 0.467 | -0.109 | 0.295 | 0.123 | 0.401 | 0.000 | 0.122 | -0.424 | 0.000 | 0.063 | -0.451 | 0.000 |
| pO2 | 0.575 | 0.096 | 0.353 | 0.380 | -0.036 | 0.739 | 0.249 | -0.335 | 0.001 | 0.027 | -0.249 | 0.015 |
| pCO2 | 0.265 | -0.171 | 0.097 | 0.365 | -0.044 | 0.671 | 0.413 | -0.179 | 0.082 | 0.916 | 0.232 | 0.024 |
| HCO3 | 0.069 | 0.158 | 0.127 | 0.090 | -0.251 | 0.014 | 0.567 | -0.235 | 0.002 | 0.150 | 0.113 | 0.276 |
| BE | 0.013 | 0.257 | 0.012 | 0.144 | -0.285 | 0.005 | 0.663 | 0.289 | 0.004 | 0.491 | 0.194 | 0.060 |
| Lactate | 0.541 | -0.198 | 0.055 | 0.796 | 0.261 | 0.011 | 0.058 | 0.219 | 0.033 | 0.217 | -0195 | 0.059 |
| Albumin | 0.556 | -0.027 | 0.798 | 0.113 | 0.007 | 0.943 | 0.074 | -0.236 | 0.021 | 0.051 | -0.337 | 0.001 |
| CRP | 0.600 | -0.006 | 0.953 | 0.932 | -0.152 | 0.141 | 0.291 | -0.150 | 0.146 | 0.364 | 0.372 | 0.000 |
| PCT | 0.372 | -0.044 | 0.671 | 0.400 | -0.022 | 0.831 | 0.106 | -0.145 | 0.161 | 0.493 | -0.097 | 0.348 |
| TSH | 0.587 | -0.069 | 0.508 | 0.248 | 0.111 | 0.165 | 0.079 | 0.095 | 0.359 | 0.026 | -0.067 | 0.548 |
| FT3 | 0.089 | 0.039 | 0.706 | 0.007 | -0.102 | 0.326 | 0.028 | -0.236 | 0.021 | 0.198 | -0.249 | 0.015 |
| FT4 | 0.000 | -0.084 | 0.420 | 0.000 | 0.006 | 0.951 | 0.021 | -0.334 | 0.001 | 0.011 | -0.331 | 0.001 |
Table 3 Correlation of the effects of vasoactive agents and inflammatory prognostic scores with fatal outcome
| Variable | T0, day 0 | T1, day 1 | T2, day 3 | T3, day 7 | ||||||||
| P value1 | r | P value2 | P value1 | r | P value2 | P value1 | r | P value2 | P value1 | r | P value2 | |
| Effects of vasoactive agents | ||||||||||||
| VDI | 0.389 | -0.125 | 0.229 | 0.074 | -0.122 | 0.229 | 0.814 | -0.128 | 0.217 | 0.842 | -0.122 | 0.237 |
| SI | 0.206 | -0.155 | 0.134 | 0.080 | -0.197 | 0.134 | 0.027 | -0.182 | 0.078 | 0.000 | 0.268 | 0.009 |
| Inflammatory prognostic scores | ||||||||||||
| NLR | 0.712 | 0.264 | 0.010 | 0.689 | 0.259 | 0.010 | 0.236 | 0.281 | 0.006 | 0.176 | 0.337 | 0.001 |
| PLR | 0.351 | -0.160 | 0.120 | 0.367 | -0.193 | 0.120 | 0.200 | 0.214 | 0.037 | 0.659 | -0.145 | 0.162 |
| mGPS | 0.496 | 0.060 | 0.566 | 0.030 | -0.224 | 0.566 | 0.128 | -0.106 | 0.306 | 0.308 | -0.108 | 0.298 |
| PI | 0.328 | 0.220 | 0.032 | 0.305 | 0.286 | 0.005 | 0.100 | 0.239 | 0.019 | 0.327 | 0.283 | 0.006 |
- Citation: Kovacevic M, Nesek-Adam V, Klokic S, Yilmaz M. Determinants of fatal outcome in septic shock patients with euthyroid sick syndrome. World J Crit Care Med 2026; 15(1): 115599
- URL: https://www.wjgnet.com/2220-3141/full/v15/i1/115599.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v15.i1.115599
